Monitoring in real time the cytotoxic effect of Clostridium difficile upon the intestinal epithelial cell line HT29

Journal of Microbiological Methods

Volumn 119, Issue , 2015, Pages 66-73

  Valdés, Lorena ^a   Gueimonde, Miguel ^a   Ruas Madiedo, Patricia ^a  

^a DEPARTMENT OF MICROBIOLOGY AND BIOCHEMISTRY OF DAIRY PRODUCTS   (Spain)

Author keywords

Clostridium difficile; HT29; RT CES; RTCA; Toxins; XCELLigence

Indexed keywords

ACTIN FILAMENT; ARTICLE; CACO 2 CELL LINE; CELL DEATH; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; EC50; HT 29 CELL LINE; HUMAN; HUMAN CELL; NONHUMAN; PEPTOCLOSTRIDIUM DIFFICILE; PRIORITY JOURNAL; TIME LAPSE IMAGING; CELL PROLIFERATION; CLOSTRIDIUM INFECTION; CYTOLOGY; DRUG EFFECTS; EVALUATION STUDY; GENETICS; INTESTINE; METABOLISM; MICROBIOLOGY; PROCEDURES;

BACTERIAL TOXIN;

BACTERIAL TOXINS; CELL PROLIFERATION; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CYTOLOGICAL TECHNIQUES; HT29 CELLS; HUMANS; INTESTINES;

EID: 84943624042     PISSN: 01677012     EISSN: 18728359     Source Type: Journal    
DOI: 10.1016/j.mimet.2015.09.022     Document Type: Article

References (41)

1. Abou-Chakra C.N., Pepin J., Sirard S., Valiquette L. Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review. PLoS One 2014, 9(6).
2. Boetzkes A., Wiebke Felkel K., Zeiser J., Jochim N., Just I., Pich A. Secretome analysis of Clostridium difficile strains. Arch. Microbiol. 2012, 194:675-687.
3. Bouillaut L., Self W.T., Sonenshein A.L. Proline-dependent regulation of Clostridium difficile Stickland metabolism. J. Bacteriol. 2013, 195:844-854.
4. Carter G.P., Rood J.I., Lyras D. The role of toxin A and toxin B in the virulence of Clostridium difficile. Trends Microbiol. 2012, 20:21-29.
5. Drudy D., Harnedy N., Fanning S., Hannan M., Kyne L. Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile. Infect. Control Hosp. Epidemiol. 2007, 28:932-940.
6. Duncan P.I., Fotopoulos G., Pasche E., Porta N., Elmelegy I.M., Sanchez-Garcia J.L., Bergonzelli G.E., Corthésy-Theulaz I. Yeast, beef and pork extracts counteract Clostridium diffcile toxin A enterotoxicity. FEMS Microbiol. Lett. 2009, 295:218-225.
7. Dunne M., Mertens H.D.T., Garefalaki V., Jeffries C.M., Thompson A., Lemke E.A., Svergun D.I., Mayer M.J., Narbad A., Meijers R. The CD27L and CTP1L endolysins rargeting Clostridia contain a built-in trigger and release factor. PLoS Pathog. 2014, 10(7).
8. Faris B., Blackmore A., Haboubi N. Review of medical and surgical management of Clostridium difficile infection. Tech. Coloproctol. 2010, 14:97-105.
9. Gebhart D., Lok S., Clare S., Tomas M., Stares M., Scholl D., Donskey C.J., Lawley T.D., Govonia G.R. A modified R-Type bacteriocin specifically targeting Clostridium difficile prevents colonization of mice without affecting gut microbiota diversity. mBio 2015, 6(2).
10. Gerding D.N., Johnson S., Rupnik M., Aktories K. Clostridium difficile binary toxin CDT: mechanism, epidemiology, and potential clinical importance. Gut Microbes 2014, 5:15-57.
11. Govind R., Dupuy B. Secretion of Clostridium difficile toxins A and B requires the holin-like protein TcdE. PLoS Pathog. 2012, 8(6).
12. He X., Wang J., Steele J., Sun X., Nie W., Tzipori S., Feng H. An ultrasensitive rapid immunocytotoxicity assay for detecting Clostridium difficile toxins. J. Microbiol. Methods 2009, 78:97-100.
13. Hidalgo-Cantabrana C., Kekkonen R., de los Reyes-Gavilán C.G., Salminen S., Korpeta R., Gueimonde M., Ruas-Madiedo P. Effect of bacteria used in food industry on the proliferation and cytokine production. J. Funct. Foods 2014, 6:348-355.
14. Hilgendorf C., Spahn-Langguth H., Regardh C.G., Lipka E., Amidon G.L., Langguth P. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport. J. Pharm. Sci. 2000, 89:63-75.
15. Huang B., Li H., Jin D., Stratton C.W., Tang Y.W. Real-time cellular analysis for quantitative detection of functional Clostridium difficile toxin in stool. Expert. Rev. Mol. Diagn. 2014, 14:281-291.
16. Huang B., Jin D., Zhang J., Sun J.Y., Wang X., Stiles J., Xu X., Kamboj M., Babady N.E., Tang Y.W. Real-time cellular analysis coupled with a specimen enrichment accurately detects and quantifies Clostridium difficile toxins in stool. J. Clin. Microbiol. 2014, 52:1105-1111.
17. Jank T., Aktories K. Structure and mode of action of clostridial glucosylating toxins: the ABCD model. Trends Microbiol. 2008, 16:222-229.
18. Jeffery B., Barlow T., Moizer K., Paul S., Boyle C. Amnesic shellfish poison. Food Chem. Toxicol. 2004, 42:545-557.
19. Kesavan S.V., Momey F., Cioni O., David-Watine B., Dubrulle N., Shorte S., Sulpice E., Freida D., Chalmond B., Dinten J.M., Gidrol X., Allier C. High-throughput monitoring of major cell functions by means of lensfree video microscopy. Sci. Rep. 2014, 4:5942.
20. Kim H., Riley T.V., Kim M., Kim C.K., Yong D., Lee K., Chong Y., Park J.W. Increasing prevalence of Toxin A-negative, Toxin B-positive isolates of Clostridium difficile in Korea: impact on laboratory giagnosis. J. Clin. Microbiol. 2008, 46:1116-1117.
21. Lei X.H., Bochner B.R. Using phenotype microarrays to determine culture conditions that induce or repress toxin production by Clostridium difficile and other microorganisms. PLoS One 2013, 8(2).
22. Limame R., Wouters A., Pauwels B., Fransen E., Peeters M., Lardon F., De Wever O., Pauwels P. Comparative analysis of dynamic cell viability, migration and invasion assessments by novel real-time technology and classic endpoint assays. PLoS One 2012, 7(10).
23. Mathur H., Rea M.C., Cotter P.D., Ross R.P., Hill C. The potential for emerging therapeutic options for Clostridium difficile infection. Gut Microbes 2014, 5:696-710.
24. May M., Wang T., Müller M., Genth H. Difference in F-actin depolymerization induced by toxin B from the Clostridium difficile strain VPI 10463 and toxin B from the variant Clostridium difficile Serotype F strain 1470. Toxicology 2013, 5:106-119.
25. Olling A., Seehase S., Minton N.P., Tatge H., Schröter S., Kohlscheen S., Pich A., Just I., Gerhard R. Release of TcdA and TcdB from Clostridium difficile cdi 630 is not affected by functional inactivation of the tcdE gene. Microb. Pathog. 2012, 52:92-100.
26. Rodriguez-Palacios A., Borgmann S., Kline T.R., LeJeune J.T. Clostridium difficile in foods and animals: history and measures to reduce exposure. Anim. Health Res. Rev. 2013, 14:11-29.
27. Rupnik M. Heterogeneity of large clostridial toxins: importance of Clostridium diffcile toxinotypes. FEMS Microbiol. Rev. 2008, 32:541-555.
28. Rupnik M., Wilcox M.H., Gerding D.N. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat. Rev. Microbiol. 2009, 7:526-536.
29. Ryder A.B., Huang Y., Li H., Zheng M., Wang X., Stratton C.W., Xu X., Tang Y.W. Assessment of Clostridium difficile infections by quantitative detection of TcdB toxin by use of a real-time cell analysis system. J. Clin. Microbiol. 2010, 48:4129-4164.
30. Schwan C., Kruppke A.S., Nölke T., Schumacher L., Koch-Nolte F., Kudryashev M., Stahlberg H., Aktories K. Clostridium difficile toxin CDT hijacks microtubule organization and reroutes vesicle traffic to increase pathogen adherence. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:2313-2318.
31. Shen A. Clostridium difficile toxins: mediators of inflammation. J. Innate Immun. 2012, 4:149-158.
32. Slanina H., König A., Claus H., Frosch M., Schubert-Unkmeir A. Real-time impedance analysis of host cell response to meningococcal infection. J. Microbiol. Methods 2011, 84:101-108.
33. Steele J., Chen K., Sun X., Zhang Y., Wang H., Tzipori S., Feng H. Systemic dissemination of Clostridium difficile toxins A and B is associated with severe, fatal disease in animal models. J. Infect. Dis. 2012, 205:384-391.
34. Sun X., Hirota S.A. The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection. Mol. Immunol. 2015, 63:193-202.
35. Tam J., Beilhartz G.L., Auger A., Gupta P., Therien A.G., Melnyk R.A. Small molecule inhibitors of Clostridium difficile toxin B-induced cellular damage. Chem. Biol. 2015, 22:175-185.
36. van Nood E., Vrieze A., Nieuwdorp M., Fuentes S., Zoetendal E.G., de Vos W.M., Visser C.E., Kuijper E.J., Bartelsman J.F.W.M., Tijssen J.G.P., Speelman P., Dijkgraaf M.G.W., Keller J.J. Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Engl. J. Med. 2013, 368:407-415.
37. Voth D.E., Ballard J.D. Clostridium difficile toxins: mechanism of action and role in disease. Clin. Microbiol. Rev. 2005, 18:247-263.
38. Xi B., Yu N., Wang X., Xu X., Abassi Y.A. The application of cell-based label-free technology in drug discovery. Biotechnol. J. 2008, 3:484-495.
39. Ye J., Luo Y., Fang W., Pan J., Zhang Z., Zhang Y., Chen Z., Jin D. Real-time cell analysis for monitoring cholera toxin-induced human intestinal epithelial cell response. Curr. Microbiol. 2015, 70:536-543.
40. Yu N., Atienza J.M., Bernard J., Blanc S., Zhu J., Wang X., Xu X., Abassi Y.A. Real-time monitoring of morphological changes in living cells by electronic cell sensor arrays: an approach to study G protein-coupled receptors. Anal. Chem. 2006, 78:35-43.
41. Yu H., Chen K., Wu J., Yang Z., Shi L., Barlow L.L., Aronoff D.M., Garey K.W., Savidge T.C., von Rosenvinge E.C., Kelly C.P., Feng H. Identification of toxemia in patients with Clostridium difficile infection. PLoS One 2015, 10(4).